Literature DB >> 28755808

Potential role of CXCL10/CXCR3 signaling in the development of morphine tolerance in periaqueductal gray.

Wei Wang1, Yawen Peng1, Hui Yang1, Huilian Bu2, Genhua Guo1, Daiqiang Liu1, Bin Shu1, Xuebi Tian1, Ailin Luo1, Xuming Zhang3, Feng Gao4.   

Abstract

Tolerance to morphine antinociception hinders its long-term use in clinical practice. Interaction between neuron and microglia has been proved to play critical role in the mechanism of morphine tolerance, while CXCL10/CXCR3 signaling has been implicated in neuron-glia signaling and morphine analgesia. This study aims to investigate whether CXCL10/CXCR3 signaling in periaqueductal gray (PAG) contributes to the development of morphine tolerance by modulating neuron-microglia interaction. The results showed that the expressions of CXCR3 and CXCL10 were gradually increased in parallel with repeated morphine administration and activation of microglia. CXCR3 was co-localized with neuronal marker NeuN, while CXCL10 was derived from microglia. Microglia inhibitor minocycline significantly attenuated the expression of CXCL10, besides, both minocycline and CXCR3 inhibitor alleviated the development of morphine tolerance. Taken together, our study provided the evidence that CXCL10/CXCR3 signaling in PAG is involved in the development of morphine analgesic tolerance via neuron-microglia interaction.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CXCL10; CXCR3; Chemokine; Morphine tolerance

Mesh:

Substances:

Year:  2017        PMID: 28755808     DOI: 10.1016/j.npep.2017.07.004

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

1.  NADPH-Oxidase 2 Promotes Autophagy in Spinal Neurons During the Development of Morphine Tolerance.

Authors:  Xuyang Xiao; Huilian Bu; Zhisong Li; Zheng Li; Qian Bai; Zhitao Wang; Lin Yan; Daiqiang Liu; Xiaoling Peng; Xiaoqian Jia; Feng Gao
Journal:  Neurochem Res       Date:  2021-05-18       Impact factor: 3.996

Review 2.  Targeting Cytokines for Morphine Tolerance: A Narrative Review.

Authors:  Dai-Qiang Liu; Ya-Qun Zhou; Feng Gao
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

3.  Effect of heat shock protein 70 modulators on the development of morphine analgesic tolerance in rats.

Authors:  Wangjun Qin; Lei Zhang; Kun Tang; Li Zhao; Min Mao; Yanting Wang; Jianhui Liang; Xianglin Zhang; Pengmei Li
Journal:  Behav Pharmacol       Date:  2020-04       Impact factor: 2.277

4.  CXCR4 inhibition with AMD3100 attenuates amphetamine induced locomotor activity in adolescent Long Evans male rats.

Authors:  Briana Mason; Corey Calhoun; Victoria Woytowicz; Latifa Pina; Roshninder Kanda; Curtis Dunn; Antonio Alves; S Tiffany Donaldson
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240

5.  Endoplasmic Reticulum Stress in Spinal Cord Contributes to the Development of Morphine Tolerance.

Authors:  Daiqiang Liu; Yaqun Zhou; Yawen Peng; Peng Su; Zheng Li; Qiaoqiao Xu; Ye Tu; Xuebi Tian; Hui Yang; Zhen Wu; Wei Mei; Feng Gao
Journal:  Front Mol Neurosci       Date:  2018-03-06       Impact factor: 5.639

6.  Neuronal CXCL10/CXCR3 Axis Mediates the Induction of Cerebral Hyperexcitability by Peripheral Viral Challenge.

Authors:  Tiffany J Petrisko; Jenna Bloemer; Priyanka D Pinky; Sriraja Srinivas; Ryan T Heslin; Yifeng Du; Sharay E Setti; Hao Hong; Vishnu Suppiramaniam; Gregory W Konat; Miranda N Reed
Journal:  Front Neurosci       Date:  2020-03-24       Impact factor: 4.677

Review 7.  Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain.

Authors:  Martina Vincenzi; Michele Stanislaw Milella; Ginevra D'Ottavio; Daniele Caprioli; Ingrid Reverte; Daniela Maftei
Journal:  Life (Basel)       Date:  2022-03-09

8.  Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.

Authors:  Xinfeng Guo; Clayton A Wiley; Richard A Steinman; Yi Sheng; Beihong Ji; Junmei Wang; Liyong Zhang; Tony Wang; Mazen Zenatai; Timothy R Billiar; Qingde Wang
Journal:  J Neuroinflammation       Date:  2021-07-31       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.